Answers are grounded in this paper and cite their sources.
Graft versus host disease affects roughly 40%–60% of patients who undergo haematopoietic stem cell transplant, with a mortality rate of 15%. In rare cases, this can progress to sclerodermatous graft versus host disease, with devastating associated morbidity and mortality. In this article, a patient shares their first-hand experience of living with the disease.
No takes yet. Share an insight, caveat, or question.
Dalton et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: